カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の免疫抑制薬市場2022年：カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド

◆英語タイトル：Global Immunosuppressive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8853 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：109 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥501,120	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥751,680	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,002,240	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

免疫抑制薬は、免疫系の機能を低下させることを目的とした薬剤群であり、主に自己免疫疾患や臓器移植、特定のアレルギー反応、そして一部の炎症性疾患に使用されます。免疫系は、体内に侵入した病原体や異物に対して反応し、排除する役割を持っていますが、一部の病状においてはこの免疫反応が過剰になったり、誤って自己の組織を攻撃してしまうことがあります。免疫抑制薬は、このような不適切な免疫反応を抑えることで、患者の健康を守る役割を果たします。

免疫抑制薬には、いくつかの特徴があり、まず第一にその対象が非常に多岐にわたることが挙げられます。自己免疫疾患の治療においては、体が自己の細胞や組織を攻撃することを防ぐために利用されます。例えば、関節リウマチや全身性エリテマトーデスなどが該当します。また、移植医療においては、ドナーからの臓器を拒絶反応から守るために使用されます。これにより、移植された臓器が適切に機能し、長期にわたって生存できる可能性が高まります。

免疫抑制薬の種類は大きく分けて、主に3つあります。第一に、ステロイド系薬剤です。これらは副腎皮質ホルモンに由来し、強力な抗炎症作用を持っています。代表的なものにはプレドニゾロンやデキサメタゾンがあります。これらの薬剤は、免疫抑制だけでなく、炎症の軽減にも寄与しますが、副作用として感染症リスクの増加、骨粗しょう症、血糖値の上昇などがあるため、使用には注意が必要です。

第二に、非ステロイド系の免疫抑制薬として、抗代謝薬や免疫グロブリン、特定の生物製剤などがあります。抗代謝薬の代表的な薬剤にはアザチオプリンやミコフェノール酸モフェチルがあり、これらは細胞分裂を抑制することで免疫反応を抑えます。免疫グロブリンは、体内の抗体を調整することで免疫反応を抑える役割を果たします。さらに、近年は生物製剤が注目されており、特定の分子や細胞を標的にすることで、免疫系の特定の経路を抑制することが可能です。例えば、抗TNFα抗体や抗IL-6受容体抗体があり、自己免疫疾患や炎症性疾患の治療に広く用いられています。

第三には、T細胞を選択的に抑制する薬剤があり、その代表例としてシクロスポリンやタクロリムスがあります。これらは主に臓器移植後の拒絶反応を防ぐために使用されることが多く、T細胞の活性化を抑制することに特化しています。これにより、移植後の長期的な成功率を向上させることができます。

免疫抑制薬の使用に際しては、その効果と副作用のバランスを考慮することが不可欠です。免疫系を抑制することによって感染症のリスクが高まるため、患者は特に細菌やウイルス、真菌感染に対する注意深い管理が必要です。定期的なフォローアップや、必要に応じて抗菌薬の予防的使用などが行われることもあります。

さらに、免疫抑制薬の選択においては、患者の個別の病状や生活環境、その他の基礎疾患も考慮されるべきです。例えば、高齢者や糖尿病を患っている患者に対する免疫抑制療法は、それぞれ異なるリスクを伴うため、個々の状況に応じた慎重な判断が必要となります。今後の研究においては、これらのリスクを最小限に抑えつつ、より効果的な免疫抑制薬の開発が期待されています。

また、近年の医療技術の進歩により、遺伝子治療や細胞療法、さらにはナノテクノロジーを応用した新しい治療法が登場しています。これらの技術は、免疫系をより精密に調整することを可能にするものであり、従来の免疫抑制薬に比べて、副作用を最小限に抑えつつ、効果を最大化する可能性があります。特に、がん治療においては免疫チェックポイント阻害薬が注目を浴びています。これにより、がん細胞に対する免疫応答を高めることができる一方で、自己免疫的な副作用も懸念されています。

免疫抑制薬の研究および臨床応用は、今後もますます進展していくことが予想されます。新たな治療法が開発されることで、より多くの患者が適切な治療を享受できるようになるでしょう。ただし、これらの薬剤を使用する際には、そのメリットとリスクを十分に理解し、患者自身が医療チームと協力して治療に臨むことが重要です。今後も免疫抑制薬に関する研究が進み、さらなる治療の選択肢が増えることを期待しています。

免疫抑制薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の免疫抑制薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

免疫抑制薬市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド

用途別セグメントは次のように区分されます。
・腎臓移植、骨骨髄移植、肝移植、心臓移植、肺移植、その他

世界の免疫抑制薬市場の主要な市場プレーヤーは以下のとおりです。
・Pfizer、Sanofi、Novartis、Roche、Astellas Pharma, Inc.、GlaxoSmithKline plc、Veloxis Pharmaceuticals、Mylan、Dr Reddys Laboratories、Abbvie Inc

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、免疫抑制薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な免疫抑制薬メーカーの企業概要、2019年～2022年までの免疫抑制薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な免疫抑制薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別免疫抑制薬の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの免疫抑制薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での免疫抑制薬市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および免疫抑制薬の産業チェーンを掲載しています。
・第13、14、15章では、免疫抑制薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Sanofi、Novartis、Roche、Astellas Pharma, Inc.、GlaxoSmithKline plc、Veloxis Pharmaceuticals、Mylan、Dr Reddys Laboratories、Abbvie Inc
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド
・用途別分析2017年-2028年：腎臓移植、骨骨髄移植、肝移植、心臓移植、肺移植、その他
・免疫抑制薬の北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・免疫抑制薬のヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・免疫抑制薬のアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・免疫抑制薬の南米市場規模2017年-2028年：ブラジル、アルゼンチン
・免疫抑制薬の中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Immunosuppressive Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Immunosuppressive Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Kidney Transplant accounting for % of the Immunosuppressive Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Calcineurin Inhibitors segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Immunosuppressive Drugs include Pfizer, Sanofi, Novartis, Roche, and Astellas Pharma, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Immunosuppressive Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Calcineurin Inhibitors
Antiproliferative Agents
mTOR Inhibitors
Antibodies
Steroids
Market segment by Application can be divided into
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lungs Transplant
Others Transplant
The key market players for global Immunosuppressive Drugs market are listed below:
Pfizer
Sanofi
Novartis
Roche
Astellas Pharma, Inc.
GlaxoSmithKline plc
Veloxis Pharmaceuticals
Mylan
Dr Reddys Laboratories
Abbvie Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immunosuppressive Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immunosuppressive Drugs, with price, sales, revenue and global market share of Immunosuppressive Drugs from 2019 to 2022.
Chapter 3, the Immunosuppressive Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immunosuppressive Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Immunosuppressive Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immunosuppressive Drugs.
Chapter 13, 14, and 15, to describe Immunosuppressive Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Immunosuppressive Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immunosuppressive Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Calcineurin Inhibitors
1.2.3 Antiproliferative Agents
1.2.4 mTOR Inhibitors
1.2.5 Antibodies
1.2.6 Steroids
1.3 Market Analysis by Application
1.3.1 Overview: Global Immunosuppressive Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lungs Transplant
1.3.7 Others Transplant
1.4 Global Immunosuppressive Drugs Market Size & Forecast
1.4.1 Global Immunosuppressive Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Immunosuppressive Drugs Sales in Volume (2017-2028)
1.4.3 Global Immunosuppressive Drugs Price (2017-2028)
1.5 Global Immunosuppressive Drugs Production Capacity Analysis
1.5.1 Global Immunosuppressive Drugs Total Production Capacity (2017-2028)
1.5.2 Global Immunosuppressive Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Immunosuppressive Drugs Market Drivers
1.6.2 Immunosuppressive Drugs Market Restraints
1.6.3 Immunosuppressive Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Immunosuppressive Drugs Product and Services
2.1.4 Pfizer Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Immunosuppressive Drugs Product and Services
2.2.4 Sanofi Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Immunosuppressive Drugs Product and Services
2.3.4 Novartis Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Immunosuppressive Drugs Product and Services
2.4.4 Roche Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Astellas Pharma, Inc.
2.5.1 Astellas Pharma, Inc. Details
2.5.2 Astellas Pharma, Inc. Major Business
2.5.3 Astellas Pharma, Inc. Immunosuppressive Drugs Product and Services
2.5.4 Astellas Pharma, Inc. Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GlaxoSmithKline plc
2.6.1 GlaxoSmithKline plc Details
2.6.2 GlaxoSmithKline plc Major Business
2.6.3 GlaxoSmithKline plc Immunosuppressive Drugs Product and Services
2.6.4 GlaxoSmithKline plc Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Veloxis Pharmaceuticals
2.7.1 Veloxis Pharmaceuticals Details
2.7.2 Veloxis Pharmaceuticals Major Business
2.7.3 Veloxis Pharmaceuticals Immunosuppressive Drugs Product and Services
2.7.4 Veloxis Pharmaceuticals Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Immunosuppressive Drugs Product and Services
2.8.4 Mylan Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dr Reddys Laboratories
2.9.1 Dr Reddys Laboratories Details
2.9.2 Dr Reddys Laboratories Major Business
2.9.3 Dr Reddys Laboratories Immunosuppressive Drugs Product and Services
2.9.4 Dr Reddys Laboratories Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Abbvie Inc
2.10.1 Abbvie Inc Details
2.10.2 Abbvie Inc Major Business
2.10.3 Abbvie Inc Immunosuppressive Drugs Product and Services
2.10.4 Abbvie Inc Immunosuppressive Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Immunosuppressive Drugs Breakdown Data by Manufacturer
3.1 Global Immunosuppressive Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Immunosuppressive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Immunosuppressive Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Immunosuppressive Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Immunosuppressive Drugs Manufacturer Market Share in 2021
3.5 Global Immunosuppressive Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Immunosuppressive Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Immunosuppressive Drugs Market Size by Region
4.1.1 Global Immunosuppressive Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Immunosuppressive Drugs Revenue by Region (2017-2028)
4.2 North America Immunosuppressive Drugs Revenue (2017-2028)
4.3 Europe Immunosuppressive Drugs Revenue (2017-2028)
4.4 Asia-Pacific Immunosuppressive Drugs Revenue (2017-2028)
4.5 South America Immunosuppressive Drugs Revenue (2017-2028)
4.6 Middle East and Africa Immunosuppressive Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Immunosuppressive Drugs Sales in Volume by Type (2017-2028)
5.2 Global Immunosuppressive Drugs Revenue by Type (2017-2028)
5.3 Global Immunosuppressive Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Immunosuppressive Drugs Sales in Volume by Application (2017-2028)
6.2 Global Immunosuppressive Drugs Revenue by Application (2017-2028)
6.3 Global Immunosuppressive Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Immunosuppressive Drugs Sales by Type (2017-2028)
7.2 North America Immunosuppressive Drugs Sales by Application (2017-2028)
7.3 North America Immunosuppressive Drugs Market Size by Country
7.3.1 North America Immunosuppressive Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Immunosuppressive Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Immunosuppressive Drugs Sales by Type (2017-2028)
8.2 Europe Immunosuppressive Drugs Sales by Application (2017-2028)
8.3 Europe Immunosuppressive Drugs Market Size by Country
8.3.1 Europe Immunosuppressive Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Immunosuppressive Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Immunosuppressive Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Immunosuppressive Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Immunosuppressive Drugs Market Size by Region
9.3.1 Asia-Pacific Immunosuppressive Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Immunosuppressive Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Immunosuppressive Drugs Sales by Type (2017-2028)
10.2 South America Immunosuppressive Drugs Sales by Application (2017-2028)
10.3 South America Immunosuppressive Drugs Market Size by Country
10.3.1 South America Immunosuppressive Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Immunosuppressive Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Immunosuppressive Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Immunosuppressive Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Immunosuppressive Drugs Market Size by Country
11.3.1 Middle East & Africa Immunosuppressive Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Immunosuppressive Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Immunosuppressive Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Immunosuppressive Drugs
12.3 Immunosuppressive Drugs Production Process
12.4 Immunosuppressive Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Immunosuppressive Drugs Typical Distributors
13.3 Immunosuppressive Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Immunosuppressive Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Immunosuppressive Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Immunosuppressive Drugs Product and Services
Table 6. Pfizer Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Immunosuppressive Drugs Product and Services
Table 10. Sanofi Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Immunosuppressive Drugs Product and Services
Table 14. Novartis Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Immunosuppressive Drugs Product and Services
Table 18. Roche Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Astellas Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Astellas Pharma, Inc. Major Business
Table 21. Astellas Pharma, Inc. Immunosuppressive Drugs Product and Services
Table 22. Astellas Pharma, Inc. Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GlaxoSmithKline plc Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline plc Major Business
Table 25. GlaxoSmithKline plc Immunosuppressive Drugs Product and Services
Table 26. GlaxoSmithKline plc Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Veloxis Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Veloxis Pharmaceuticals Major Business
Table 29. Veloxis Pharmaceuticals Immunosuppressive Drugs Product and Services
Table 30. Veloxis Pharmaceuticals Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Immunosuppressive Drugs Product and Services
Table 34. Mylan Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Dr Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 36. Dr Reddys Laboratories Major Business
Table 37. Dr Reddys Laboratories Immunosuppressive Drugs Product and Services
Table 38. Dr Reddys Laboratories Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Abbvie Inc Basic Information, Manufacturing Base and Competitors
Table 40. Abbvie Inc Major Business
Table 41. Abbvie Inc Immunosuppressive Drugs Product and Services
Table 42. Abbvie Inc Immunosuppressive Drugs Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Immunosuppressive Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Immunosuppressive Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Immunosuppressive Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Immunosuppressive Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Immunosuppressive Drugs Production Site of Key Manufacturer
Table 48. Immunosuppressive Drugs New Entrant and Capacity Expansion Plans
Table 49. Immunosuppressive Drugs Mergers & Acquisitions in the Past Five Years
Table 50. Global Immunosuppressive Drugs Sales by Region (2017-2022) & (K Units)
Table 51. Global Immunosuppressive Drugs Sales by Region (2023-2028) & (K Units)
Table 52. Global Immunosuppressive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Immunosuppressive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Global Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 56. Global Immunosuppressive Drugs Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Immunosuppressive Drugs Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Immunosuppressive Drugs Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Immunosuppressive Drugs Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 61. Global Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 62. Global Immunosuppressive Drugs Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Immunosuppressive Drugs Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Immunosuppressive Drugs Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Immunosuppressive Drugs Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Immunosuppressive Drugs Sales by Country (2017-2022) & (K Units)
Table 67. North America Immunosuppressive Drugs Sales by Country (2023-2028) & (K Units)
Table 68. North America Immunosuppressive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Immunosuppressive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 71. North America Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 72. North America Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 73. North America Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Europe Immunosuppressive Drugs Sales by Country (2017-2022) & (K Units)
Table 75. Europe Immunosuppressive Drugs Sales by Country (2023-2028) & (K Units)
Table 76. Europe Immunosuppressive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Immunosuppressive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Europe Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Europe Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Europe Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Immunosuppressive Drugs Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Immunosuppressive Drugs Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Immunosuppressive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Immunosuppressive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 90. South America Immunosuppressive Drugs Sales by Country (2017-2022) & (K Units)
Table 91. South America Immunosuppressive Drugs Sales by Country (2023-2028) & (K Units)
Table 92. South America Immunosuppressive Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Immunosuppressive Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 95. South America Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 96. South America Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 97. South America Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Immunosuppressive Drugs Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Immunosuppressive Drugs Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Immunosuppressive Drugs Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Immunosuppressive Drugs Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Immunosuppressive Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Immunosuppressive Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Immunosuppressive Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Immunosuppressive Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Immunosuppressive Drugs Raw Material
Table 107. Key Manufacturers of Immunosuppressive Drugs Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Immunosuppressive Drugs Typical Distributors
Table 111. Immunosuppressive Drugs Typical Customers
List of Figures
Figure 1. Immunosuppressive Drugs Picture
Figure 2. Global Immunosuppressive Drugs Revenue Market Share by Type in 2021
Figure 3. Calcineurin Inhibitors
Figure 4. Antiproliferative Agents
Figure 5. mTOR Inhibitors
Figure 6. Antibodies
Figure 7. Steroids
Figure 8. Global Immunosuppressive Drugs Revenue Market Share by Application in 2021
Figure 9. Kidney Transplant
Figure 10. Bone Marrow Transplant
Figure 11. Liver Transplant
Figure 12. Heart Transplant
Figure 13. Lungs Transplant
Figure 14. Others Transplant
Figure 15. Global Immunosuppressive Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Immunosuppressive Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Immunosuppressive Drugs Sales (2017-2028) & (K Units)
Figure 18. Global Immunosuppressive Drugs Price (2017-2028) & (US$/Unit)
Figure 19. Global Immunosuppressive Drugs Production Capacity (2017-2028) & (K Units)
Figure 20. Global Immunosuppressive Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Immunosuppressive Drugs Market Drivers
Figure 22. Immunosuppressive Drugs Market Restraints
Figure 23. Immunosuppressive Drugs Market Trends
Figure 24. Global Immunosuppressive Drugs Sales Market Share by Manufacturer in 2021
Figure 25. Global Immunosuppressive Drugs Revenue Market Share by Manufacturer in 2021
Figure 26. Immunosuppressive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Immunosuppressive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Immunosuppressive Drugs Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Immunosuppressive Drugs Sales Market Share by Region (2017-2028)
Figure 30. Global Immunosuppressive Drugs Revenue Market Share by Region (2017-2028)
Figure 31. North America Immunosuppressive Drugs Revenue (2017-2028) & (USD Million)
Figure 32. Europe Immunosuppressive Drugs Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Immunosuppressive Drugs Revenue (2017-2028) & (USD Million)
Figure 34. South America Immunosuppressive Drugs Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Immunosuppressive Drugs Revenue (2017-2028) & (USD Million)
Figure 36. Global Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
Figure 37. Global Immunosuppressive Drugs Revenue Market Share by Type (2017-2028)
Figure 38. Global Immunosuppressive Drugs Price by Type (2017-2028) & (US$/Unit)
Figure 39. Global Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 40. Global Immunosuppressive Drugs Revenue Market Share by Application (2017-2028)
Figure 41. Global Immunosuppressive Drugs Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
Figure 43. North America Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 44. North America Immunosuppressive Drugs Sales Market Share by Country (2017-2028)
Figure 45. North America Immunosuppressive Drugs Revenue Market Share by Country (2017-2028)
Figure 46. United States Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
Figure 50. Europe Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 51. Europe Immunosuppressive Drugs Sales Market Share by Country (2017-2028)
Figure 52. Europe Immunosuppressive Drugs Revenue Market Share by Country (2017-2028)
Figure 53. Germany Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Immunosuppressive Drugs Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Immunosuppressive Drugs Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Immunosuppressive Drugs Revenue Market Share by Region (2017-2028)
Figure 62. China Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
Figure 69. South America Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 70. South America Immunosuppressive Drugs Sales Market Share by Country (2017-2028)
Figure 71. South America Immunosuppressive Drugs Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Immunosuppressive Drugs Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Immunosuppressive Drugs Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Immunosuppressive Drugs Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Immunosuppressive Drugs Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Immunosuppressive Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Immunosuppressive Drugs in 2021
Figure 83. Manufacturing Process Analysis of Immunosuppressive Drugs
Figure 84. Immunosuppressive Drugs Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の免疫抑制薬市場2022年：カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド(Global Immunosuppressive Drugs Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界の免疫抑制薬市場2022年：カルシニューリン阻害剤、抗増殖剤、mTOR阻害剤、抗体、ステロイド

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp